Johnston KM - Search Results

1

Cost-effectiveness of therapies for melanoma.

Johnston KM, McPherson E, Osenenko K, Vergidis J, Levy AR, Peacock S. Johnston KM, et al. Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):229-42. doi: 10.1586/14737167.2015.1017563. Epub 2015 Feb 23. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25703441 Review.

2

The direct costs of HIV/AIDS care.

Levy AR, James D, Johnston KM, Hogg RS, Harrigan PR, Harrigan BP, Sobolev B, Montaner JS. Levy AR, et al. Among authors: johnston km. Lancet Infect Dis. 2006 Mar;6(3):171-7. doi: 10.1016/S1473-3099(06)70413-3. Lancet Infect Dis. 2006. PMID: 16500598 Review.

3

Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research.

Johnston KM, Gustafson P, Levy AR, Grootendorst P. Johnston KM, et al. Stat Med. 2008 Apr 30;27(9):1539-56. doi: 10.1002/sim.3036. Stat Med. 2008. PMID: 17847052

4

Why should dentists screen for oral cancer?

Musa Z, Johnston K, Peacock S, Rosin MP, Elwood JM. Musa Z, et al. J Can Dent Assoc. 2008 Apr;74(3):243-4. J Can Dent Assoc. 2008. PMID: 18387265 Free article. No abstract available.

5

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.

Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, Montaner JS. Lima VD, et al. J Infect Dis. 2008 Jul 1;198(1):59-67. doi: 10.1086/588673. J Infect Dis. 2008. PMID: 18498241

6

Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study).

Mabasa VH, Taylor SC, Chu CC, Moravan V, Johnston K, Peacock S, Knowling M. Mabasa VH, et al. J Oncol Pharm Pract. 2008 Sep;14(3):105-12. doi: 10.1177/1078155208088695. Epub 2008 Jun 4. J Oncol Pharm Pract. 2008. PMID: 18524863

7

Comparative effectiveness research through the looking glass.

Levy A, Harrigan B, Johnston K, Briggs A. Levy A, et al. Med Decis Making. 2009 Nov-Dec;29(6):NP6-8. doi: 10.1177/0272989X09351590. Med Decis Making. 2009. PMID: 19959806

8

Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada.

Johnston KM, Marra CA, Connors JM, Najafzadeh M, Sehn L, Peacock SJ. Johnston KM, et al. Value Health. 2010 Sep-Oct;13(6):703-11. doi: 10.1111/j.1524-4733.2010.00737.x. Epub 2010 Jun 7. Value Health. 2010. PMID: 20561333 Free article.

9

Expanding access to HAART: a cost-effective approach for treating and preventing HIV.

Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, Briggs A, Montaner JS. Johnston KM, et al. AIDS. 2010 Jul 31;24(12):1929-35. doi: 10.1097/QAD.0b013e32833af85d. AIDS. 2010. PMID: 20588171

10

International comparison of comparative effectiveness research in five jurisdictions: insights for the US.

Levy AR, Mitton C, Johnston KM, Harrigan B, Briggs AH. Levy AR, et al. Among authors: johnston km. Pharmacoeconomics. 2010;28(10):813-30. doi: 10.2165/11536150-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831289 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page